Chiara Ciccarese
@ciccarese_c
Followers
158
Following
179
Media
12
Statuses
69
MD, PhD. Researcher at Università Cattolica del Sacro Cuore and Oncologist at Fondazione Policlinico Gemelli IRCCS Rome, Italy
Joined April 2020
This morning I have found this on my desk... I am so proud of this achievement! 😁 Thanks 🙏 to all investigators & @EUplatinum for supporting Academic Research in GU cancers. Stay tuned 🛜 for other news from TIDE-A trial! @Uroweb @urofocus @OncoAlert @oncodaily @GUOncologyNow
7
11
64
I am so proud of these two fellows of mine at @Unicatt who received the ASCO merit award at #GU25. 😍 Tutorship meaining is to improve young careers, allowing new experiences and sharing knowledge. @OncoAlert @ASCO @oncodaily @AIOMtweet @ciccarese_c @BriaEmilio
3
6
32
Only standing room at #AIOM24 GU cancers session. Outstanding presentations & debates about hot topics in prostate, urothelial, and renal cancer. Proud to be within the scientific committee and thanks to @AndreaNecchi @ciccarese_c @MatteoBauckneht @CPRT65 @g_procopio_ @AIOMtweet
2
7
24
La ricerca è il motore del futuro, contro questa malattia incerta e ineluttabile. Che immensa emozione oggi al Quirinale con il mio mentore @DrIacovelli per i giorni della ricerca di @AIRC_it. @Unicatt @OncoAlert
1
3
18
When you wouldn’t be anywhere else than where you are.Listening and learning from the most important Italian leaders of #RCC @DrIacovelli @CPRT65 @fabiocalabr @fmassari79 @Sebastiano_Buti @Sergio130902627 @LuigiFormisano_ @therealmarcodoc Btw all but one love my boots!Guess who
0
3
21
Started just now! 🚨
Don’t forget to sign up to the webinar on hot topics in renal cell carcinoma @UrowebESU lead by our team head @Ric_Campi and @danieleamparore
https://t.co/bX9EZgl5TZ
0
3
13
Fecal Microbiota Transplantation Boosts Response to Pembrolizumab Plus Axitinib in mRCC @myESMO @ciccarese_c #ESMO24 #kcsm #oncology #MedTwitter
https://t.co/JXubY6zy4T
onclive.com
The addition of fecal microbiota transplantation to pembrolizumab and axitinib raised the efficacy of the combination in metastatic renal cell carcinoma.
0
2
2
I’m always fascinated and enriched by @montypal presentations. Thank you for the inspiration and sharing your incredible insights! #IUCS24 #oncoalert @OncoAlert @gbanna74 @oncodaily
@montypal an exceptional and unique mentor @NazliDizman @DrIacovelli @ciccarese_c @EbrahimiHedyeh
0
12
30
🚨 Don’t miss the @UrowebESU #Webinar by YAU RCC on #October #1st! 🕕 10 PM IST (18:30 CEST) 🔹 Topics: Robot-assisted #partial #nephrectomy, #SBRT, and #adjuvant #immunotherapy. 🔹 Q&A with all YAU RCC members! 🔗 Register now: [ https://t.co/JWxRqJ0zmw] 👇 See the full
0
11
19
Faecal microbiota transplant shows promise in #TACITO trial presented by Chiara Ciccarese! ORR: 52% vs 28% in mRCC pts receiving pembro-axi. 🌱 #ESMO24 #RCC #microbiota
Fecal microbiota transplantation vs PBO in pts receiving pembrolizumab + axitinib for metastatic #RCC. Preliminary results of the randomized phase 2 #TACITO trial. Presentation by @ciccarese_c. #ESMO24 written coverage by @chavarriagaj > https://t.co/wI8I3j7Od7
@myESMO
0
6
12
Fecal microbiota transplantation vs PBO in pts receiving pembrolizumab + axitinib for metastatic #RCC. Preliminary results of the randomized phase 2 #TACITO trial. Presentation by @ciccarese_c. #ESMO24 written coverage by @chavarriagaj > https://t.co/wI8I3j7Od7
@myESMO
1
10
14
Faecal microbiota transplantation increases activity of immunotherapy in mRCC - ecancer https://t.co/QgMgcW4om3 📢📢📢about our study of FMT @OncoAlert @myESMO @DrIacovelli @gianluca1aniro @Unicatt
ecancer.org
Dr Chiara Ciccarese talks to ecancer at ESMO 2024 about data she presented from the randomized phase II TACITO trial. This looked at faecal microbiota transp
0
4
25
Catch up on all the latest news from #ESMO24 with our extensive coverage, including expert analysis of all the key trial data👇 https://t.co/ZT09StsHGA
#cancer #Oncology
0
4
6
Another adventure completed with these amazing colleagues. Friendship, mutual support, and generosity always shine through! @DrIacovelli @ciccarese_c @sjoukjelubberts @pabloteros @ @cboixareu1 @DanieleRaggi83 #ESMO24 @MassimoDiMaio75 @EORTC
2
5
25
Always a pleasure to hear the point of view of @ChrisSweens1 about #ProstateCancer at @myESMO . Wonder if biomarker-based treatment choice for mPC would be the real next future
0
0
4
After years and years of inconclusive trials in adjuvant tx of MIBC and few evidence in adjuvant therapy, @tompowles1 and NIAGARA study team show us the way to increas OS in bladder cancer and save lives! @OncoAlert @GUOncologyNow @oncodaily @PGrivasMDPhD
1
18
43
❗️❗️ One more piece of Aron Project published at @IntJCanc. RWE of mRCC with sarcomatoid features. ⬇️OS for sRCC: 26.8m vs 35.3m ⭕️ no difference across IO combos in this population. Congrats @ciccarese_c @fmassari79 @raymanneh
https://t.co/zzhuaGvDaC
0
5
12
Day 3 of #ESMO24 and a stellar presentation by @ciccarese_c on the preliminary results of the TACITO trial, exploring fecal microbiota transplantation (#FMT) in #mRCC. FMT + pembrolizumab + axitinib showed a significant increase in 1-year PFS vs. placebo, highlighting the
1
10
24
What a stellar team! 🌟 Part of the Oncology Unit of Fondazione Policlinico Gemelli IRCCS in Rome 🇮🇹 at #ESMO2024. We are leaded by a visionary boss and mentor Prof Giampaolo Tortora. @Unicatt @BriaEmilio @ciccarese_c @PalazzoA_MD @LisaSalvy @ArmandOrlandi and many, many other..
0
3
26
One of the most intriguing implications of the TACITO study presented today by @ciccarese_c at #ESMO2024 is that responders pts to immunotherapy can help other pts to achieve response and longer control of metastic kidney cancer. @KidneyCancer @IKCCorg @kidneycan @AssPalinuro
0
9
24